HUMACYTE, INC.

Profile

Company Names

HUMACYTE, INC.
HUMACYTE INC
HUMACYTE, INC

Addresses

2525 E. NC HIGHWAY 54, DURHAM, NC 27713

7020 KIT CREEK ROAD, SUITE 110, MORRISVILLE, NC 27560

7020 KIT CREEK ROAD, SUITE 230, DURHAM, NC 27709

7020 KIT CREEK ROAD, SUITE 230, DURHAM, NC 27709

Phone Numbers

919-313-9633
919-597-6224
919-913-9633

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

NORTH CAROLINA

Total Amount Raised:

$274,762,353.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-06-25 
$150,000,000.00 
$150,000,000.00 
$0.00 
Equity 
2
2018-02-23 
$74,999,980.00 
$75,000,000.00 
$20.00 
Equity 
1
2007-10-01 
$49,762,373.00 
$73,762,373.00 
$24,000,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
A. 
BOYER 
EXECUTIVE OFFICER
CARRIE 
S. 
COX 
EXECUTIVE OFFICER, DIRECTOR
BRADY 
 
DOUGAN 
DIRECTOR
BRADY 
W. 
DOUGAN 
DIRECTOR
ROBERT 
 
LANGER 
DIRECTOR
MICROCHIPS, INC.   |  ARSENAL MEDICAL, INC.   |  ALSERES PHARMACEUTICALS INC /DE   |  ECHO THERAPEUTICS, INC.   |  MICELL TECHNOLOGIES INC   |  CERULEAN PHARMA INC.   |  HUMACYTE INC   |  COMBINENT BIOMEDICAL SYSTEMS, INC.   |  TARIS BIOMEDICAL INC   |  KALA PHARMACEUTICALS, INC.   |  FIBROCELL SCIENCE, INC.   |  PREDICTIVE BIOSCIENCES, INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  T2 BIOSYSTEMS, INC.   |  SEMPRUS BIOSCIENCES CORP   |  LIQUIDX, INC.   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  SELECTA BIOSCIENCES INC   |  STEMNION, INC.   |  480 BIOMEDICAL, INC.   |  LIVING PROOF INC   |  DX BIOSCIENCES, INC.   |  MODERNA LLC   |  HUMACYTE, INC   |  XTUIT PHARMACEUTICALS, INC.   |  SQZ BIOTECHNOLOGIES CO   |  NOVEOME BIOTHERAPEUTICS, INC.   |  LYNDRA, INC.   |  MODERNA THERAPEUTICS, INC.   |  VERSEAU THERAPEUTICS, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  SUONO BIO, INC.   |  COMBINED THERAPEUTICS, INC.   |  HUMACYTE, INC.   |  SEER BIOSCIENCES, INC.   |  LANDSDOWNE LABS, LLC   |  LIKEMINDS, INC./DE   |  TARVEDA THERAPEUTICS, INC.   |  LUMINOPIA, INC.   |  LYRA THERAPEUTICS, INC.   |  ABPRO CORP   |  GLYMPSE BIO, INC.   |  EPIBONE, INC.   |  TEAL BIO, INC.   |  ZWI THERAPEUTICS, INC.   |  LYNDRA THERAPEUTICS, INC.   |  KENDALL CAPITAL PARTNERS I, L.P.   |  BILAYER THERAPEUTICS, INC.   |  XENTER, INC.   |  VIVTEX CORP   |  SYNTIS BIO, INC.   |  OMNIPULSE BIOSCIENCES, INC.
JEFFREY 
H. 
LAWSON 
EXECUTIVE OFFICER
TED 
 
LITHGOW 
EXECUTIVE OFFICER
THEODORE 
 
LITHGOW 
EXECUTIVE OFFICER
THEODORE 
D. 
LITHGOW 
EXECUTIVE OFFICER
MATTHEW 
 
MEGARO 
DIRECTOR
LAURA 
 
NIKLASON 
DIRECTOR
LAURA 
E. 
NIKLASON 
DIRECTOR, EXECUTIVE OFFICER
DALE 
A. 
SANDER 
DIRECTOR
KATHLEEN 
 
SEBELIUS 
DIRECTOR
WILLIAM 
 
TENTE 
EXECUTIVE OFFICER
MAX 
 
WALLACE 
DIRECTOR
MAX 
N. 
WALLACE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2007-10-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2007-10-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2007-10-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2007-10-01 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2007-10-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#